No Cover Image

Journal article 1011 views 103 downloads

Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort

Daniel Harris, Arron Lacey, Ashley Akbari Orcid Logo, Daniel Obaid Orcid Logo, Dave A. Smith, Geraint H. Jenkins, James P. Barry, Michael Gravenor Orcid Logo, Julian Halcox Orcid Logo

Journal of the American Heart Association, Volume: 8, Issue: 21, Start page: A74

Swansea University Authors: Daniel Harris, Arron Lacey, Ashley Akbari Orcid Logo, Daniel Obaid Orcid Logo, Michael Gravenor Orcid Logo, Julian Halcox Orcid Logo

  • 40257.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).

    Download (1.24MB)
Published in: Journal of the American Heart Association
ISSN: 0735-1097 2047-9980
Published: Ovid Technologies (Wolters Kluwer Health) 2019
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa40257
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2018-05-18T03:59:24Z
last_indexed 2023-02-15T03:49:35Z
id cronfa40257
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2023-02-14T15:37:46.9557805</datestamp><bib-version>v2</bib-version><id>40257</id><entry>2018-05-17</entry><title>Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post&#x2013;Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort</title><swanseaauthors><author><sid>e60c9c73b645f0e8033ae26fa8e634b8</sid><firstname>Daniel</firstname><surname>Harris</surname><name>Daniel Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b69d245574e754d2637cc9e76379fe11</sid><firstname>Arron</firstname><surname>Lacey</surname><name>Arron Lacey</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>1cb4b49224d4f3f2b546ed0f39e13ea8</sid><ORCID>0000-0002-3891-1403</ORCID><firstname>Daniel</firstname><surname>Obaid</surname><name>Daniel Obaid</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>70a544476ce62ba78502ce463c2500d6</sid><ORCID>0000-0003-0710-0947</ORCID><firstname>Michael</firstname><surname>Gravenor</surname><name>Michael Gravenor</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-05-17</date><deptcode>FGMHL</deptcode><abstract/><type>Journal Article</type><journal>Journal of the American Heart Association</journal><volume>8</volume><journalNumber>21</journalNumber><paginationStart>A74</paginationStart><paginationEnd/><publisher>Ovid Technologies (Wolters Kluwer Health)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0735-1097</issnPrint><issnElectronic>2047-9980</issnElectronic><keywords>Clopidogrel, myocardial infarction, post&#x2013;percutaneous coronary intervention,</keywords><publishedDay>5</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-11-05</publishedDate><doi>10.1161/jaha.119.012812</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-02-14T15:37:46.9557805</lastEdited><Created>2018-05-17T22:19:00.2679409</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Health Data Science</level></path><authors><author><firstname>Daniel</firstname><surname>Harris</surname><order>1</order></author><author><firstname>Arron</firstname><surname>Lacey</surname><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Daniel</firstname><surname>Obaid</surname><orcid>0000-0002-3891-1403</orcid><order>4</order></author><author><firstname>Dave A.</firstname><surname>Smith</surname><order>5</order></author><author><firstname>Geraint H.</firstname><surname>Jenkins</surname><order>6</order></author><author><firstname>James P.</firstname><surname>Barry</surname><order>7</order></author><author><firstname>Michael</firstname><surname>Gravenor</surname><orcid>0000-0003-0710-0947</orcid><order>8</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>9</order></author></authors><documents><document><filename>40257__15934__17174f9e03db40eab094b6116d27acd9.pdf</filename><originalFilename>40257.pdf</originalFilename><uploaded>2019-11-21T14:33:42.7897644</uploaded><type>Output</type><contentLength>1299835</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807>
spelling 2023-02-14T15:37:46.9557805 v2 40257 2018-05-17 Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort e60c9c73b645f0e8033ae26fa8e634b8 Daniel Harris Daniel Harris true false b69d245574e754d2637cc9e76379fe11 Arron Lacey Arron Lacey true false aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 1cb4b49224d4f3f2b546ed0f39e13ea8 0000-0002-3891-1403 Daniel Obaid Daniel Obaid true false 70a544476ce62ba78502ce463c2500d6 0000-0003-0710-0947 Michael Gravenor Michael Gravenor true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2018-05-17 FGMHL Journal Article Journal of the American Heart Association 8 21 A74 Ovid Technologies (Wolters Kluwer Health) 0735-1097 2047-9980 Clopidogrel, myocardial infarction, post–percutaneous coronary intervention, 5 11 2019 2019-11-05 10.1161/jaha.119.012812 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2023-02-14T15:37:46.9557805 2018-05-17T22:19:00.2679409 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Health Data Science Daniel Harris 1 Arron Lacey 2 Ashley Akbari 0000-0003-0814-0801 3 Daniel Obaid 0000-0002-3891-1403 4 Dave A. Smith 5 Geraint H. Jenkins 6 James P. Barry 7 Michael Gravenor 0000-0003-0710-0947 8 Julian Halcox 0000-0001-6926-2947 9 40257__15934__17174f9e03db40eab094b6116d27acd9.pdf 40257.pdf 2019-11-21T14:33:42.7897644 Output 1299835 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC). true
title Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
spellingShingle Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
Daniel Harris
Arron Lacey
Ashley Akbari
Daniel Obaid
Michael Gravenor
Julian Halcox
title_short Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
title_full Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
title_fullStr Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
title_full_unstemmed Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
title_sort Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
author_id_str_mv e60c9c73b645f0e8033ae26fa8e634b8
b69d245574e754d2637cc9e76379fe11
aa1b025ec0243f708bb5eb0a93d6fb52
1cb4b49224d4f3f2b546ed0f39e13ea8
70a544476ce62ba78502ce463c2500d6
3676f695eeda169d0f8c618adf27c04b
author_id_fullname_str_mv e60c9c73b645f0e8033ae26fa8e634b8_***_Daniel Harris
b69d245574e754d2637cc9e76379fe11_***_Arron Lacey
aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari
1cb4b49224d4f3f2b546ed0f39e13ea8_***_Daniel Obaid
70a544476ce62ba78502ce463c2500d6_***_Michael Gravenor
3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox
author Daniel Harris
Arron Lacey
Ashley Akbari
Daniel Obaid
Michael Gravenor
Julian Halcox
author2 Daniel Harris
Arron Lacey
Ashley Akbari
Daniel Obaid
Dave A. Smith
Geraint H. Jenkins
James P. Barry
Michael Gravenor
Julian Halcox
format Journal article
container_title Journal of the American Heart Association
container_volume 8
container_issue 21
container_start_page A74
publishDate 2019
institution Swansea University
issn 0735-1097
2047-9980
doi_str_mv 10.1161/jaha.119.012812
publisher Ovid Technologies (Wolters Kluwer Health)
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Health Data Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Health Data Science
document_store_str 1
active_str 0
published_date 2019-11-05T03:51:16Z
_version_ 1763752517591629824
score 11.016771